Savara (SVRA) Net Equity Issued and Repurchased (2011 - 2019)
Savara's (SVRA) quarterly Net Equity Issued and Repurchased came in at $1000.0 in Q4 2019, down 91.67% year-on-year from $12000.0 in Q4 2018, and down 99.98% on a QoQ basis from $5.7 million in Q3 2019.
Savara (SVRA) Net Equity Issued and Repurchased (2011 - 2019) Analysis & Trends
Savara (SVRA) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $1000.0 in Q4 2019.
- On a quarterly basis, Net Equity Issued and Repurchased fell 91.67% year-over-year to $1000.0 in Q4 2019; TTM through Dec 2020 was $5.7 million, a 80.86% decrease from a year earlier, with the FY2024 full-year figure at $24.4 million, up 177.27% from the prior year.
- Net Equity Issued and Repurchased for Q4 2019 stood at $1000.0, down from $5.7 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for SVRA reached as high as $19.0 million in Q2 2019 and fell as low as -$7.3 million in Q2 2016.
- Historically, Net Equity Issued and Repurchased has averaged $3.1 million across 5 years, with a median of $675000.0 in 2017.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 89455.56% in 2016 and fell as far as 441.81% in 2016.
- Year by year, Net Equity Issued and Repurchased stood at $6.6 million in 2015, then sank by 99.91% to $6000.0 in 2016, then surged by 11150.0% to $675000.0 in 2017, then plunged by 98.22% to $12000.0 in 2018, then sank by 91.67% to $1000.0 in 2019.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $1000.0 in Q4 2019, $5.7 million in Q3 2019, and $19.0 million in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Sep 30, 2019 | 5.66 Mn |
| Sep 30, 2019 | 5.66 Mn |
| Jun 30, 2019 | 19.04 Mn |
| Jun 30, 2019 | 19.04 Mn |
| Mar 31, 2019 | 4.89 Mn |
| Mar 31, 2019 | 4.89 Mn |
| Dec 31, 2018 | 12,000.00 |
| Dec 31, 2018 | 12,000.00 |
| Mar 31, 2018 | 493,000.00 |
| Mar 31, 2018 | 493,000.00 |
| Dec 31, 2017 | 675,000.00 |
| Dec 31, 2017 | 675,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Jun 30, 2016 | -7.28 Mn |
| Jun 30, 2016 | -7.28 Mn |
| Mar 31, 2016 | 8.06 Mn |
| Mar 31, 2016 | 8.06 Mn |